SEC Form D · filed April 13, 2016
Kala Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Robert Paull · Waltham, MADirectorRobert Tepper · Waltham, MADirectorCharles B. Mcdermott · Waltham, MAExecHoward B. Rosen · Waltham, MADirectorKevin Bitterman · Waltham, MADirectorMark Iwicki · Waltham, MAExec · DirectorRobert Langer · Waltham, MADirectorRajeev B. Shah · Waltham, MADirectorHongming B. Chen · Waltham, MAExecKim Brazzell · Waltham, MAExecGreg Grunberg · Waltham, MADirectorMichael I. Iscove · LOS ANGELES, CADirectorBernard I. Luskin · LOS ANGELES, CAExecKim I. Halvorsen · LOS ANGELES, CADirectorDavid L. Rensink · SIOUX FALLS, SDDirectorDarren J. Kottle · San Francisco, CAExecChen B. Yu · Waltham, MADirectorAdam Mendelsohn · Emeryville, CAExec · DirectorKathleen Fischer · Emeryville, CAExec · DirectorW. D. Baker · Emeryville, CADirectorAaron Mendelsohn · Emeryville, CADirectorLily Peng · Emeryville, CAExecKarey Barker · Salt Lake City, UTDirectorTyler Christenson · Salt Lake City, UTExec · DirectorPeter Jarman · Salt Lake City, UTDirectorJoseph M. Stanford · Brandon, SDDirectorSidhartha Singh · New York, NYExecChen B. Yu · Waltham, MADirectorGreg Grunberg · Waltham, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗